Metacrine, Inc. Common Stock
MTCR
MTCR was delisted on the 8th of February, 2023.
47 hedge funds and large institutions have $82.1M invested in Metacrine, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
12% more funds holding
Funds holding: 42 → 47 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.33% less ownership
Funds ownership: 51.27% → 50.94% (-0.33%)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
22% less capital invested
Capital invested by funds: $105M → $82.1M (-$22.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$2.13M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.3M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.19M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$465K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$423K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.4M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$2.29M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.66M |
| 4 |
Millennium Management
New York
|
-$366K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$254K |
MTCR Hedge Fund Activity: Q1 2021 in Review
47 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q1 2021, worth a combined $82.1M — down 22% from $105M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MTCR positions and 1 closed out — a net gain of 5 holders — while 12 added to existing stakes and 15 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $2.13M. The largest seller was EcoR1 Capital, cutting an estimated $2.4M.
- 47 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q1 2021, up from 42 in Q4 2020.
- Funds reported $82.1M of Metacrine, Inc. Common Stock stock for Q1 2021, down 22% quarter-over-quarter.
- 6 funds opened new Metacrine, Inc. Common Stock positions in Q1 2021 and 1 closed out, a net change of +5 holders.
- The largest Metacrine, Inc. Common Stock buyer in Q1 2021 was JP Morgan Chase, an estimated $2.13M added.
- The largest Metacrine, Inc. Common Stock seller in Q1 2021 was EcoR1 Capital, an estimated $2.4M sold.
Based on aggregated 13F filings for Q1 2021.